TerminatedPhase 2/3

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

Stopped: Numbe of eligible patients has been decreased over time.

Thailand64 participantsStarted 2003-07

Plain-language summary

Background: Pulmonary involvement in leptospirosis has been reported to be on the increase and is emerging as the main cause of death due to leptospirosis in many countries, including Thailand. Methods: A prospective randomized controlled trial of desmopressin or high dose dexamethasone as adjunctive therapy in patients with suspected pulmonary hemorrhage associated with leptospirosis was conducted between July 2003 and October 2006 at 5 hospitals in Thailand.

Who can participate

Age range15 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients (\> 14 years) with suspected severe leptospirosis * patients who presented with acute fever (oral temperature more than 38.00 C for \<15 days) in the absence of an obvious focus of infection * In the opinion of the attending physician might have pulmonary hemorrhage (i.e. history of hemoptysis, and/ or bilateral nodular or air space infiltration). Exclusion Criteria: * pregnant or breastfeeding * those with history of bleeding disorder * those who had underlying diseases such as chronic liver disease, diabetes mellitus * those who received diuretic or glucocorticoid

What they're measuring

Survival

Timeframe: during in hospital admission

Trial details

NCT IDNCT00592566

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-10

View on ClinicalTrials.gov More Leptospirosis trials